Mary Padilla

The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays

Andrea Babic, Isabell R. Loftin, Stacey Stanislaw et al. · Methods · 2010 · 68 citations

Medicine, Molecular Biology, Pathology +15

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

Hiroaki Nitta, Brian Kelly, Mary Padilla et al. · Diagnostic Pathology · 2012 · 59 citations · Full text

Medicine, Molecular Biology, Oncology +16

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Sasagu Kurozumi, Mary Padilla, Masafumi Kurosumi et al. · Breast Cancer Research and Treatment · 2016 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +15

SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

Elizabeth Gray, Michelle Ulrich, Angela Epp et al. · Journal for ImmunoTherapy of Cancer · 2023 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab

Howard M. Stern, Mary Padilla, Klaus W. Wagner et al. · Clinical Cancer Research · 2010 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17